Induction of doxorubicin-mediated apoptosis via thioredoxin reductase 1 RNAi in human colon cancer cells
暂无分享,去创建一个
[1] L. Szekely,et al. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. , 2009, Free radical biology & medicine.
[2] J. Harvey,et al. H2AX phosphorylation as a genotoxicity endpoint. , 2009, Mutation research.
[3] P. Jeggo,et al. DNA double-strand breaks: their cellular and clinical impact? , 2007, Oncogene.
[4] A. Holmgren,et al. The thioredoxin system in cancer. , 2006, Seminars in cancer biology.
[5] V. Gladyshev,et al. Thioredoxin Reductase 1 Deficiency Reverses Tumor Phenotype and Tumorigenicity of Lung Carcinoma Cells* , 2006, Journal of Biological Chemistry.
[6] Richard A. Miller,et al. The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy , 2005, Cancer Biology & Therapy.
[7] M. Brechbiel,et al. Thioredoxin Reductase as a Potential Molecular Target for Anticancer Agents That Induce Oxidative Stress , 2004, Cancer Research.
[8] Elias S. J. Arnér,et al. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. , 2004, Antioxidants & redox signaling.
[9] Stephen J Kron,et al. Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy* , 2004, Journal of Biological Chemistry.
[10] K. O’Neill,et al. The neutral comet assay is sufficient to identify an apoptotic ‘window’ by visual inspection , 1996, Apoptosis.
[11] Joon-Hyuk Choi,et al. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. , 2002, Anticancer research.
[12] M. Kruszewski,et al. A modified neutral comet assay: elimination of lysis at high temperature and validation of the assay with anti-single-stranded DNA antibody. , 2002, Mutation research.
[13] Elias S. J. Arnér,et al. Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.
[14] R. V. Vander Heide,et al. Molecular basis of anthracycline-induced cardiotoxicity and its prevention. , 2000, Molecular genetics and metabolism.
[15] Elias S. J. Arnér,et al. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] V. Gladyshev,et al. Redox Regulation of Cell Signaling by Selenocysteine in Mammalian Thioredoxin Reductases* , 1999, The Journal of Biological Chemistry.
[17] D. Gewirtz,et al. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. , 1999, Biochemical pharmacology.
[18] M. Kunkel,et al. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. , 1998, Biochemical pharmacology.
[19] N. Bachur,et al. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. , 1977, Molecular pharmacology.
[20] S. Siegel,et al. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. , 1976, Cancer research.